0001437749-24-018625.txt : 20240529 0001437749-24-018625.hdr.sgml : 20240529 20240529175854 ACCESSION NUMBER: 0001437749-24-018625 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240524 FILED AS OF DATE: 20240529 DATE AS OF CHANGE: 20240529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Slover Peter T CENTRAL INDEX KEY: 0001468012 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42001 FILM NUMBER: 241000013 MAIL ADDRESS: STREET 1: 3115 MERRYFIELD ROW CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Contineum Therapeutics, Inc. CENTRAL INDEX KEY: 0001855175 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 271467257 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10578 SCIENCE CENTER DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 333-5280 MAIL ADDRESS: STREET 1: 10578 SCIENCE CENTER DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Pipeline Therapeutics, Inc. DATE OF NAME CHANGE: 20210405 4 1 rdgdoc.xml OPTION GRANT X0508 4 2024-05-24 0001855175 Contineum Therapeutics, Inc. CTNM 0001468012 Slover Peter T 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 1 Chief Financial Officer 0 Stock Option (right to buy) 15.76 2024-05-24 4 A 0 100000 0 A 2034-05-23 Class A Common Stock 100000 100000 D Options granted under the Issuer's 2024 Equity Incentive Plan. 25% of the option shares vest on April 5, 2025, and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's continuous service. /s/ Peter Slover 2024-05-29